Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6122693 | Journal of Infection | 2016 | 8 Pages |
Abstract
Differences in capsular group and fHBP distribution among culture and non-culture cases may be indicative of variation in strain viability, diagnostic practice, disease severity and/or clinical presentation. Future analyses combining clinical case information with laboratory data may help to further explore these differences. Group B isolates provide a good representation of group B disease in E&W and, therefore, can reliably be used in fHBP strain coverage predictions of recently-licensed vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Stephen A. Clark, Aiswarya Lekshmi, Jay Lucidarme, Li Hao, How Tsao, Lisa Lee-Jones, Kathrin U. Jansen, Lynne S. Newbold, Annaliesa S. Anderson, Ray Borrow,